Glaucoma Laser & Surgery in Burbank & Greater Los Angeles

Glaucoma rarely announces the moment it outgrows eye drops. It shows up quietly, in a number. The pressure reading at your appointment has crept up, or your optic nerve photographs and visual field show change even though you have been faithful with the bottle every night. Sometimes the drops simply stop being practical. They sting, they redden the eye, the schedule becomes a burden, or several together still are not enough. And in certain eyes, the trouble was never really about medication at all. The angle where fluid is supposed to drain is too narrow, or it has begun to close.

Any of those is a turning point. It does not mean something has gone wrong, and it does not mean blindness is around the corner. It means the strategy needs to change: from lowering pressure with medicine to lowering it with a laser or a procedure.

The encouraging part is how much that middle ground has grown. The choice is no longer just "drops" or "major surgery." Between them now sits a tier of laser treatments and micro-procedures built to improve the eye's own drainage with far less disruption than glaucoma surgery once demanded. Which one fits depends entirely on your type of glaucoma, your eye pressure, the anatomy of your drainage angle, and how your nerve is faring. That is an exam-level decision, not a webpage-level one. What follows is the map.

What every one of these procedures is trying to do

Drop, laser, or surgery: they all chase a single target, lowering the pressure inside the eye to a level the optic nerve can live with. Glaucoma damage is permanent and cannot be undone, so the entire effort is about protecting the sight you still have. Lower pressure is the one factor shown again and again to slow the disease.

Lasers and surgery pursue that goal structurally rather than chemically. Instead of a drop that reduces how much fluid the eye makes, or helps drain what is already there, these procedures act on the drainage structures themselves. They open a blocked pathway, improve flow through the eye's natural drain, or create a new route out. Below are the options Tuli Eye Care Center turns to most, arranged roughly from the lightest touch upward.

The laser and surgical ladder, lightest touch first

These are not ranked best-to-worst. They solve different problems, and the one that fits you is the one matched to your anatomy and your numbers.

• YAG Peripheral Iridotomy (PI), for narrow or closed drainage angles. This answers a specific anatomical problem: an angle that is crowded or closing, which can block fluid from reaching the drain and, at its worst, trigger a sudden, painful, sight-threatening pressure spike known as an acute angle-closure attack. Using a focused YAG laser, a tiny opening is made in the periphery of the iris, so fluid trapped behind it can pass straight through and equalize the pressure on both sides, letting the iris settle back and the drainage angle reopen. Dr. Tuli performs YAG PI in the office, with numbing drops, and it takes only minutes. For eyes identified as anatomically narrow and at meaningful risk, a PI may be performed preventively, to defuse an attack before it ever happens.

• SLT, or Selective Laser Trabeculoplasty, to improve the eye's own drainage. SLT treats the trabecular meshwork, the spongy tissue through which most of the eye's fluid normally exits. Its name carries the key idea: selective. The laser targets only specific pigmented cells in the meshwork and leaves the surrounding tissue untouched, prompting a biological healing response that improves outflow and lowers pressure. Because it does not burn or scar the tissue, SLT is repeatable: it can be performed again later if its effect fades. It has also earned a place as a legitimate first-line option, not merely a fallback after drops fail. In the landmark UK LiGHT trial, 74.2% of patients treated with SLT first stayed off drops and at their target pressure three years on, and the authors concluded SLT "should be offered as a first-line treatment for open angle glaucoma and ocular hypertension." Used as initial therapy, SLT lowers eye pressure by roughly 20% to 30%, comparable to the most commonly prescribed class of glaucoma drop. Dr. Tuli performs SLT in the office; the treatment itself takes a few minutes, with the surface of the eye numbed.

• MIGS, or Minimally Invasive Glaucoma Surgery: micro-procedures, often paired with cataract surgery. MIGS is not one operation but a family of them: tiny procedures, performed through micro-incisions, that lower pressure by enhancing the eye's natural drainage with markedly less trauma and quicker recovery than traditional glaucoma surgery. Some open or bypass the trabecular meshwork; others widen the eye's natural drainage canal. A frequent and convenient pairing is with cataract surgery. If you need both, the glaucoma step can often be added during the same trip to the operating room, addressing two problems at once. MIGS is generally suited to mild-to-moderate glaucoma, and its pressure-lowering varies widely by device. For the trabecular-bypass procedures most often paired with cataract surgery, the drop in pressure is frequently modest, with much of the value showing up as needing fewer drops rather than a dramatic change in the number. Dr. Tuli performs iStent, a trabecular-bypass MIGS device — either at the time of cataract surgery or as a standalone procedure, depending on the patient. Which MIGS approach makes sense for your eye, and whether your case is better served by a fellowship-trained glaucoma surgeon, is determined by your exam and your stage of disease.

For more advanced or aggressive glaucoma, traditional surgical options such as trabeculectomy or a drainage-tube implant remain important tools. When a case points that way, Tuli Eye Care Center will say so plainly and make sure your care is coordinated with the right surgical specialist.

Where comprehensive ophthalmology fits your glaucoma care

A word on scope, because it matters and patients rarely get a straight answer about it. Dr. Suhas Tuli is a board-certified, comprehensive ophthalmologist — fellowship-trained at Johns Hopkins' Wilmer Eye Institute and USC's Doheny Eye Institute, and recognized as a Castle Connolly Top Doctor. Glaucoma detection, monitoring, and management sit squarely within the practice of comprehensive ophthalmology, and the value of seeing it through one practice is continuity. Your pressures, your nerve, your fields, and your lens are all tracked together over time, by someone who knows your eyes.

That continuity comes with an obligation to be honest about thresholds. Some glaucoma is best co-managed alongside a fellowship-trained glaucoma surgeon, and a comprehensive ophthalmologist's job includes knowing precisely when a case has reached that line and making the handoff seamless. The aim is never to keep a procedure in-house for its own sake. It is to put your optic nerve in the right hands at the right time.

A frank word on what these procedures can and cannot do

No laser or surgery cures glaucoma, and none of them gives back vision the disease has already taken. Their job is to lower pressure and slow the damage going forward, which, with glaucoma, is the whole ballgame. Some honest expectations worth setting before anything is scheduled:

• Results are neither guaranteed nor permanent. SLT's effect can fade over a few years, which is exactly why its repeatability matters. MIGS outcomes vary by device and by eye. You may still need some drops afterward, on a lighter regimen rather than none.
• Every procedure carries risk. A short-lived pressure spike can follow laser treatment. Inflammation, bleeding, or, less commonly, an unexpectedly low pressure can follow MIGS. Serious complications are uncommon, but they are real, and each will be reviewed with you before you decide.
• Glaucoma is a lifelong condition. Even after a successful procedure, the monitoring does not stop. Pressure checks, optic-nerve imaging, and visual-field testing continue, because the only way to know a treatment is holding is to keep watching.